Alnylam Pharmaceuticals

Scientist, Metabolomics

Alnylam Pharmaceuticals  •  $110k - $166k/yr  •  United States (Onsite)  •  3 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Alnylam’s Translational Research group is seeking a highly motivated Metabolomics Scientist to join our team. We use untargeted and targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based omics and computational biology to support biomarker discovery and target validation efforts for our RNAi-based therapeutics. The successful candidate will have a background in biological sample preparation for endogenous metabolites/lipids, LC-MS/MS operation/troubleshooting, and omics-level data analysis.

This position is onsiteand will be primarily located in Cambridge, MA.

Key Responsibilities

  • Design, validate, and apply LC-MS/MS methods for endogenous metabolite and lipid quantification to identify and measure biomarkers, characterize pharmacodynamic activity of novel therapeutic molecules, and answer foundational biological questions.
  • Perform end-to-end metabolite/lipid sample preparation protocols for biofluids, solid tissues, and cultured cells.
  • Operate, maintain, and troubleshoot LC-MS systems as needed.
  • Develop and apply bioinformatics tools for large-scale data processing and statistical analysis.
  • Identify and onboard novel technologies for biomarker measurement and identification.
  • Maintain QC records, analyze data, and document protocols/results in a clearly organized electronic lab notebook.
  • Collaborate with cross-disciplinary and external teams to support preclinical and clinical drug discovery activities.
  • Contribute to preclinical/clinical study design and biomarker strategies for drug candidate programs.
  • Serve as subject matter expert for general questions pertaining to translational biology.
  • Present results at internal/external meetings and author findings in reports/manuscripts.

Qualifications

  • PhD in analytical chemistry, biochemistry, chemical engineering, biological engineering, or related field required, with post-doctoral experience a plus; or MS with 8+ years’ experience, preferably in pharma/biotech.
  • Direct experience with triple-quadrupole and high-resolution accurate mass LC-MS/MS-based methods for endogenous metabolite/lipid quantification (ideally with Sciex QTRAP and Thermo Orbitrap systems), including assay development and validation.
  • Experience with metabolite/lipid extraction sample preparation from biofluids, tissues, and/or cultured cells.
  • Experience with relevant omics-based bioinformatics software; familiarity with basic programming languages (e.g. Python or R) and/or AI-based coding tools (e.g. Claude Code or Codex) is a strong plus.
  • Experience with stable isotope tracing and/or metabolic flux analysis is also a plus.
  • A strong publication record and demonstration of successful collaborations.
  • Strong written and oral communication skills.
  • Strong abilities to work both independently and in a team environment.

Intellectual curiosity, a passion for science, critical thinking skills, and a willingness to ask questions.

#LI-JR1

U.S. Pay Range

$110,400.00 - $165,600.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Alnylam Pharmaceuticals

About Alnylam Pharmaceuticals

SILENCE DISEASE. AMPLIFY LIFE.™

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.

We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).

We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.

See our social media community guidelines: https://bit.ly/2FcRhJy.

Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Fraudulent Recruitment Activity

Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
Cambridge, Massachusetts
Year Founded
2002
Social Media